SecBot SecBot
Insider Cluster (4 insiders) ·Filed Aug 12, 2026

MRK

Merck & Co., Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 4 insiders, $4.3M total
Actionable Insight • Neutral

This insider selling cluster is routine and immaterial given the tiny dollar value relative to market cap. No bearish signal. Monitor for any future insider buying or larger sales that exceed 0.1% of market cap, which would warrant attention. The Q2 earnings beat and raised guidance remain the dominant fundamental narrative.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$135.55
T+0 close · Aug 12, 2026 · via day close
Latest settled
+8.25%
T+60 · $146.73
Vs SPY
+13.72%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 13 $135.55entry
  2. T+1 · 3mo ago +0.21%α +0.41% · $135.84
  3. T+5 · 3mo ago +9.92%α +11.88% · $148.99
  4. T+20 · 2mo ago +6.18%α +7.93% · $143.93
  5. T+60 · 10d ago +8.25%α +13.72% · $146.73
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Multiple Merck executives, including the EVP of Animal Health, EVP of Access/Policy/Comms, EVP/Chief Digital Officer, and EVP of MMD, sold a combined ~$4.34M in open-market sales over a 7-day window following Q2 earnings. The cluster is dominated by C-suite-level executives, but the total value is only ~0.0013% of Merck's $321.8B market cap, making it trivial relative to company size. Per academic literature, insider sales are weak predictors and cluster sales are not more informative than non-cluster sales, especially at this scale. The sales likely reflect routine portfolio diversification or tax planning, not a bearish view on the company's fundamentals, which were solid in Q2 (revenue beat, raised guidance).

Key Financial Metrics

Direction
selling
Total Value
$4.3M
Insiders
4

Key Facts

  • Four Merck executives sold shares totaling ~$4.34M in open-market transactions between Aug 4-11, 2026.
  • The sales represent approximately 0.0013% of Merck's $321.8B market cap, well below the 0.1% threshold for materiality.
  • Sales occurred shortly after Merck reported Q2 2026 revenue of $16.6B (+5% YoY) and raised full-year sales guidance.
  • All transactions were open-market sales (code S); no insider buying was reported in the cluster.
  • The cluster includes EVP-level executives from Animal Health, Access/Policy/Comms, IT/Digital, and MMD divisions.

Financial Impact

Total insider sales of ~$4.34M, which is negligible relative to Merck's $321.8B market cap.

insider_sales

Risk Factors

  • Insider sales, while small, could be followed by larger sales if executives continue to reduce positions.
  • The cluster occurred post-earnings, which is a common window for routine sales, no incremental risk beyond normal diversification.

Market Snapshot

Price
$132.87
Volume
500
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
69% bullish (36 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MRK-1786611780927

Track record

34 reports on MRK

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +16.92% at T+20 after the Aug 6, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 12, 20263d ago 144 Neutral 2/10 Entry $146.91 Now $144.90 −1.37% settles Feb 11
  2. Nov 9, 20267d ago PTAB Trial Neutral 2/10 Entry $148.05 Now $144.90 −2.13% settles Feb 8
  3. Nov 3, 202613d ago 3 Neutral 2/10 Entry $144.67 Now $144.90 +0.16% settles Feb 1
  4. Nov 3, 202613d ago Institutional Cluster Bearish 4/10 Entry $144.67 Now $144.90 −0.16% settles Feb 1
  5. Nov 2, 202613d ago 144 Neutral 2/10 Entry $144.67 Now $144.90 +0.16% settles Feb 1
  6. Oct 29, 202618d ago 8-K Neutral 5/10 Entry $146.33 Now $144.90 −0.98% settles Jan 27
  7. Oct 22, 202625d ago 3/A Neutral 1/10 Entry $145.27 Now $144.90 −0.25% settles Jan 21
  8. Oct 21, 202626d ago PTAB Trial Neutral 3/10 Entry $147.24 Now $144.90 −1.59% settles Jan 20
  9. Oct 15, 20264w ago PTAB Trial Bullish 6/10 Entry $145.95 Now $144.90 −0.72% settles Jan 13
  10. Oct 15, 20264w ago PTAB Trial Bullish 5/10 Entry $145.95 Now $144.90 −0.72% settles Jan 13
Showing 10 of 34

US Market Status

Market Open · Closes in 14m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 13, 2026